Home » Roche Plans Dollar Bonds for Genentech Offer
Roche Plans Dollar Bonds for Genentech Offer
Swiss drugmaker Roche Holding plans a six-part U.S. dollar global bond to help finance its $42 billion hostile offer for U.S. biotechnology company Genentech Inc, an official at a bank managing the sale said.
CNBC
CNBC
Upcoming Events
-
07May
-
14May
-
30May